Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients (SWITCH)

This study has been completed.
Information provided by (Responsible Party):
Genomic Health®, Inc. Identifier:
First received: September 1, 2010
Last updated: April 17, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)